Most recent articles by:
Pavlos Giorkas
Pavlos Giorkas is a blogger and content creator with a passion for crypto, health, consumer tech and money management. He's been dealing with cryptocurrency since 2013 but didn't take action until 3 years later on 2016. On Bitnewsbot he covers the latest news in the crypto space.
News
Elon Musk Becomes First Person With $500 Billion Net Worth
Elon Musk has become the first person ever to surpass a net worth of $500 billion.Increases in the value of SpaceX and Artificial Intelligence...
News
Abu Dhabi’s MGX, T. Rowe Price Buy Shares in OpenAI $6.6B Sale
OpenAI employees completed a $6.6 billion stock sale to external investors.The deal pushed OpenAI’s company valuation to $500 billion.Investors included Thrive Capital, SoftBank, Dragoneer,...
News
Crypto Rallies as U.S. Shutdown Looms, Japan Yields Spike
Cryptocurrencies held strong despite a potential U.S. government shutdown and turbulence in Japan’s bond market.Bitcoin, ether, solana, and Dogecoin saw significant gains, with total...
News
Morgan Stanley Stock Soars 25% in 2025: Buy, Sell, or Hold?
Morgan Stanley shares have increased 25.3% in 2025, after rising 63.9% in the previous year.The stock is currently trading at around $157, raising questions...
News
Zcash Surges After ThorSwap Support Despite UAE Exchange Delistings
ZCash reached a three-year price high after being listed on ThorSwap.
New trading support allows Zcash to swap with major cryptocurrencies like Bitcoin, Ethereum, and...
News
Bitcoin Analysts Eye ETFs, Regulation, Adoption as October Begins
Bitcoin market outlook hinges on adoption rates and new U.S. crypto regulations this October.Recent stablecoin legislation and SEC policy changes aim to make crypto...
News
SEC Puts Spot Altcoin ETF Approvals on Hold Amid Shutdown
SEC has paused decisions on spot altcoin ETF applications due to a government shutdown.
Analysts had anticipated approvals for Solana-based ETFs in early October, but...
News
Pfizer Shares Soar After Trump Drug Deal, $70B Investment Pledge
Pfizer shares surged nearly 7%, their highest since January, after announcing a drug pricing deal with the U.S. government.
The agreement involves sharp price cuts...
